Obata, Yoko
Takazono, Takahiro
Tashiro, Masato
Ota, Yuki
Wakamura, Tomotaro
Takahashi, Akinori
Sato, Kumiko
Miyazaki, Taiga
Nishino, Tomoya
Izumikawa, Koichi
Funding for this research was provided by:
Dainippon Sumitomo Pharma
Article History
Received: 19 May 2020
Accepted: 29 October 2020
First Online: 11 November 2020
Change Date: 8 January 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s10157-020-02004-5
Compliance with ethical standards
:
: K.I. received honorarium and research grant from Sumitomo Dainippon Pharma Co., Ltd. T.W. is a full-time employee of Sumitomo Dainippon Pharma Co., Ltd. A.T. and K.S. are full-time employees of Deloitte Tohmatsu Consulting LLC. Deloitte Tohmatsu Consulting LLC receives consulting fees from Sumitomo Dainippon Pharma Co., Ltd.
: All procedures performed in the studies involving human participants were in accordance with the ethical standards of the institutional and/or the national research committee at which the studies were conducted (IRB approval number 18033038-5) as well as the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: As the data analyzed in the present study were anonymously processed by the database provider in accordance with the Act on the Protection of Personal Information of Japan and other related regulations, requirement for informed consent from the patients was waived according to the Japanese Ethical Guidelines for Medical and Health Research Involving Human Subjects by the Ministry of Education, Culture, Sports, Science, and Technology and the Ministry of Health, Labour, and Welfare of Japan.